Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 482
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05769348 Investigation and Modulation of the Central Mu-Opioid Mechanism in Migr… |
HD-tDCS Active Protocol | Migraine | Non applicable | RECRUITING | En attente / non publié | University of Michigan | United States · University of Michigan, Ann Arbor, Un… | 2023-01-26 → 2026-12-30 | Ouvrir |
| NCT04616326 REBUILD-2 — A Study of Galcanezumab (LY2951742) in Participants 12 to 1… |
Galcanezumab | Migraine | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | The Cleveland Clinic | United States, Denmark, France, Germany, India, Italy… | 2020-11-25 → 2027-03 | Ouvrir |
| NCT07656922 Scapular Muscle Activation and Shoulder Performance in Migraine |
Scapular Muscle Activation and Sh… | Migraine | À vérifier | RECRUITING | En attente / non publié | Ankara Yildirim Beyazıt University | Turkey (Türkiye) · Ankara Yıldırım Beyazıt University… | 2026-04-01 → 2026-07-15 | Ouvrir |
| NCT07655700 Comparison of Propranolol, Flunarizine and Their Combination in Prevent… |
Propranolol 80 mg | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Chittagong Medical College | Bangladesh · Chittagong Medical College, Chittagong, … | 2026-07-01 → 2027-04-30 | Ouvrir |
| NCT05342493 Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term… |
Fremanezumab 225 Mg/1.5 mL Subcut… | Migraine | À vérifier | RECRUITING | En attente / non publié | Otsuka Pharmaceutical Co., Ltd. | Japan · Pharmacovigilance Department, Osaka, Japan | 2022-04-20 → 2029-06-22 | Ouvrir |
| NCT05582837 Treatment of Meniere's Disease With Migraine Medications |
nortriptyline + topiramate | Migraine | Phase 4 | RECRUITING | En attente / non publié | University of California, Irvine | United States · University of California, Irvine Medi… | 2022-08-01 → 2027-12-30 | Ouvrir |
| NCT04396574 PIONEER-PEDS2 — A 12-Month Study of Lasmiditan (LY573144) Treatment in … |
Lasmiditan | Migraine | Phase 3 | TERMINATED | En attente / non publié | University of Florence | United States, Belgium, Canada, France, Germany, Indi… | 2020-06-30 → 2025-12-04 | Ouvrir |
| NCT07671703 Multimodal Physiotherapy Intervention for People With Migraine |
Multimodal Physiotherapy Interven… | Migraine | Non applicable | RECRUITING | En attente / non publié | Hochschule Osnabruck | Germany · Capu Motion: Die Physio- und Ergotherapeute… | 2026-02-11 → 2028-12-31 | Ouvrir |
| NCT06808230 CORAL — Cocoa Extract for Migraine Trial |
CORAL — Cocoa Extract for Migrain… | Migraine | Non applicable | RECRUITING | En attente / non publié | Brigham and Women's Hospital | United States · Brigham and Women's Hospital, Boston,… | 2025-06-23 → 2026-12-01 | Ouvrir |
| NCT06692881 Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult P… |
Study to Assess Function and Sati… | Migraine | À vérifier | COMPLETED | En attente / non publié | AbbVie | Canada · 360 Concussion Care /ID# 271972, Ottawa, Can… | 2025-02-12 → 2026-06-01 | Ouvrir |
| NCT06467370 CONFIDENCE — A Real-world, Prospective Observational Study of Rimegepan… |
CONFIDENCE — A Real-world, Prospe… | Migraine | À vérifier | COMPLETED | En attente / non publié | Pfizer | United States · Pfizer, New York, United States | 2024-07-02 → 2025-03-11 | Ouvrir |
| NCT07487701 Migraine Prevention With the Remote Electrical Neuromodulation (REN) We… |
Nerivio REN device | Migraine | Non applicable | COMPLETED | En attente / non publié | Theranica | United States · Theranica Bio-Electronics Inc, Bridge… | 2026-02-20 → 2026-04-15 | Ouvrir |
| NCT07653516 Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness |
Fremanezumab 225 Mg/1.5 mL Subcut… | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Otsuka Pharmaceutical Co., Ltd. | Switzerland · Bern University Hospital, Bern, Switzer… | 2027-06-01 → 2027-07-31 | Ouvrir |
| NCT07681466 CHRONOpS — Chronology and Sequence of Premonitory Symptoms |
CHRONOpS — Chronology and Sequenc… | Migraine | À vérifier | RECRUITING | En attente / non publié | University of Roma La Sapienza | Italy · Sapienza University of Rome, Polo Pontino, ce… | 2026-03-17 → 2027-09 | Ouvrir |
| NCT06899074 Omega-3 Supplementation for Pediatric Migraine |
Omega-3 Supplementation for Pedia… | Migraine | Non applicable | COMPLETED | En attente / non publié | University of North Carolina, Cha… | United States · University of North Carolina at Chape… | 2025-04-17 → 2026-03-18 | Ouvrir |
| NCT07501520 HistaMed-MS — Effect of Low Histamine-Based Modified Mediterranean Diet… |
HistaMed-MS — Effect of Low Hista… | SEP | Non applicable | COMPLETED | En attente / non publié | Firat University | Turkey (Türkiye) · Firat University Hospital, Neurolo… | 2024-06-15 → 2025-06-10 | Ouvrir |
| NCT02266329 Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial o… |
prazosin hydrochloride | Migraine | Phase 1/2 | COMPLETED | En attente / non publié | VA Office of Research and Develop… | United States · VA Puget Sound Health Care System Sea… | 2016-01-04 → 2023-09-30 | Ouvrir |
| NCT06417775 UBRO MM — Study of Oral Ubrogepant to Assess Adverse Events and Change … |
Ubrogepant | Migraine | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | AbbVie | United States, Puerto Rico · Abington Neurological As… | 2024-09-10 → 2027-11 | Ouvrir |
| NCT03461757 Trial in Adult Subjects With Acute Migraines |
Rimegepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | University of South Florida | United States · AGA Clinical Trials, Hialeah, United … | 2018-02-27 → 2018-10-15 | Ouvrir |
| NCT03177616 IMPACT — Integrative Migraine Pain Alleviation Through Chiropractic The… |
IMPACT — Integrative Migraine Pai… | Migraine | Non applicable | COMPLETED | En attente / non publié | Harvard University Faculty of Med… | United States · The Osher Clinical Center for Integra… | 2017-06-07 → 2022-11-04 | Ouvrir |
| NCT05565001 The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and… |
Levcromakalim | Migraine | Non applicable | UNKNOWN | En attente / non publié | Danish Headache Center | Denmark · Danish Headache Center, Copenhagen, Denmark | 2022-09-01 → 2023-07-31 | Ouvrir |
| NCT05018572 Digital Treatment for Migraines - a Feasibility Study |
Digital Treatment for Migraines -… | Migraine | Non applicable | COMPLETED | En attente / non publié | Vastra Gotaland Region | Sweden · FoU primary care Södra Älvsborg, Borås, Swed… | 2021-07-01 → 2022-10-14 | Ouvrir |
| NCT05635604 Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine… |
Eptinezumab | Migraine | Non applicable | COMPLETED | En attente / non publié | H. Lundbeck A/S | Denmark · Danish Headache Center, Glostrup Municipali… | 2023-03-01 → 2023-08-04 | Ouvrir |
| NCT04568252 MISTIC — Migraine STImulation Crisis of Migraine |
Wristband with millimeter wave em… | Migraine | Non applicable | COMPLETED | En attente / non publié | Remedee SA | France · Cabinet Mornant, Mornant, France | Cabinet N… | 2020-12-04 → 2023-01-10 | Ouvrir |
| NCT03901482 EMERGE — A Randomized, Double-Blind, Placebo-Controlled Study to Evalua… |
Dihydroergotamine | Migraine | Phase 3 | COMPLETED | En attente / non publié | Satsuma Pharmaceuticals, Inc. | United States · Accel - Orange City, Orange City, Uni… | 2019-06-24 → 2020-08-13 | Ouvrir |